Novel active fixation mechanism permits precise placement of a left ventricular lead: early results from a multicenter clinical study

Yee R 1 , Gadler F 2 , Hussin A 3 , Bin Omar R 3 , Khaykin Y 4 , Verma A 4 Show all authors , Lazeroms M 5 , Hine DS 6 , Marquard KR 6

Affiliations 

  • 1 London Health Sciences Center, London, Ontario, Canada. Electronic address: ryee@uwo.ca
  • 2 Karolinska Hospital, Stockholm, Sweden
  • 3 Institut Jantung Negara, Kuala Lumpur, Malaysia
  • 4 Southlake Regional Health Center, Newmarket, Ontario, Canada
  • 5 Medtronic Bakken Research Center, Maastricht, The Netherlands
  • 6 Medtronic, Inc, Minneapolis, Minnesota
Heart Rhythm, 2014 Jul;11(7):1150-5.
PMID: 24801899 DOI: 10.1016/j.hrthm.2014.04.020

Abstract

Left ventricular (LV) lead implantation for cardiac resynchronization therapy (CRT) is associated with lead dislodgement rates ranging from 3% to 10%, and some implant approaches to prevent dislodgement may contribute to suboptimal CRT response. We report our early human experience with an LV lead with a side helix for active fixation to the coronary vein wall.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications